Technologies

Medical Sciences

Title:

Clot-Specific Streptokinase - The Third Generation Clot Buster

Area:

Medical Sciences

Focus Area:

Production of Streptokinase

Social Benefits:

A clot-buster drug with minimal side effects has been highly desirable. This function i.e. the ability to dissolve the pathological blood clot without plasminogen activation through the circulatory system is a highly coveted and premium property in any clot buster drug of choice.

Developing Agency:

CSIR-Institute of Microbial Technology (IMT), Chandigarh

Technology Readiness Index:

Market Launch

Email:

director@imtech.res.in
Website Link :http://www.imtech.res.in
Source (more info) :https://t.ly/l_sb

Brief Description

Description :

Process for the production of clot specific streptokinase which dissolve the pathological blood clot without plasminogen activation.

Related Technologies